Latest News
February 3, 2023
New developments and barriers to palliative care
February 3, 2023
MDedge Hematology and Oncology
February 3, 2023
‘Exciting’: Post-SCT, antiviral T-cell therapy shows promise
February 3, 2023
MDedge Hematology and Oncology
February 3, 2023
Quality of life predicts chemo tolerance in early breast cancer
February 3, 2023
MDedge Hematology and Oncology
February 3, 2023
Black patients less likely to receive opioids for advanced cancer
February 3, 2023
MDedge Hematology and Oncology
Conference Coverage
January 30, 2023
Dermatopathologist reflects on the early history of melanoma
January 30, 2023
TBD Meeting (5455)
MDedge Hematology and Oncology
January 27, 2023
New ‘reference regimen’ in metastatic pancreatic cancer?
January 27, 2023
GI Cancers Symposium
MDedge Hematology and Oncology
January 27, 2023
SUNLIGHT shows new standard of care in refractory metastatic CRC
January 27, 2023
GI Cancers Symposium
MDedge Hematology and Oncology
January 27, 2023
Adding SBRT to sorafenib boosts survival in liver cancer
January 27, 2023
GI Cancers Symposium
MDedge Hematology and Oncology
January 27, 2023
Regorafenib: New option for advanced gastroesophageal cancer?
January 27, 2023
GI Cancers Symposium
MDedge Hematology and Oncology
January 27, 2023
How should PRAME be used to evaluate melanocytic lesions?
January 27, 2023
TBD Meeting (5455)
MDedge Hematology and Oncology
Opinion
February 3, 2023
New developments and barriers to palliative care
February 3, 2023
MDedge Hematology and Oncology
January 26, 2023
75 years: A look back on the fascinating history of methotrexate and folate antagonists
January 26, 2023
MDedge Hematology and Oncology
January 26, 2023
My patient chose quality of life over treatment
January 26, 2023
MDedge Hematology and Oncology
COVID-19 News
February 3, 2023
New developments and barriers to palliative care
February 3, 2023
MDedge Hematology and Oncology
February 2, 2023
Inflammation and immunity troubles top long-COVID suspect list
February 2, 2023
MDedge Hematology and Oncology
February 2, 2023
COVID emergency orders ending: What’s next?
February 2, 2023
MDedge Hematology and Oncology
February 1, 2023
Washington medical board charges doctor with spreading COVID misinformation
February 1, 2023
MDedge Hematology and Oncology
News from the FDA/CDC
January 27, 2023
FDA pulls authorization for AstraZeneca’s COVID-19 treatment Evusheld
January 27, 2023
MDedge Hematology and Oncology
October 3, 2022
FDA approves futibatinib (Lytgobi) for certain biliary tract cancers
October 3, 2022
MDedge Hematology and Oncology
September 22, 2022
FDA OKs sodium thiosulfate injection to reduce ototoxicity risk in children with cancer
September 22, 2022
MDedge Hematology and Oncology
Policy & Practice
February 2, 2023
Three wishes: The changes health professionals want
February 2, 2023
MDedge Hematology and Oncology
February 2, 2023
Using live pigs in residency training sparks heated debate
February 2, 2023
MDedge Hematology and Oncology
February 1, 2023
Washington medical board charges doctor with spreading COVID misinformation
February 1, 2023
MDedge Hematology and Oncology
January 31, 2023
Difficulty fitting family into career: Female oncologists
January 31, 2023
MDedge Hematology and Oncology
Medicine’s Lighter Side
Livin' on the MDedge
February 2, 2023
The long-range thrombolysis forecast calls for tiny ultrasonic tornadoes
February 2, 2023
MDedge Hematology and Oncology
January 26, 2023
The longevity gene: Healthy mutant reverses heart aging
January 26, 2023
MDedge Hematology and Oncology
January 18, 2023
It’s all about the brains: Guilt placebos, transplants, and negative feelings
January 18, 2023
MDedge Hematology and Oncology
January 12, 2023
Early retirement and the terrible, horrible, no good, very bad cognitive decline
January 12, 2023
MDedge Hematology and Oncology
Clinical Edge Journal Scan
January 27, 2023
Commentary: HER2+-targeted therapy, ovarian suppression, and adjuvant therapy in breast cancer, February 2023
January 27, 2023
MDedge Hematology and Oncology
December 22, 2022
Commentary: Early Breast Cancer Treatment Strategies and Acupuncture, January 2023
December 22, 2022
MDedge Hematology and Oncology
November 29, 2022
Commentary: HER2-Positive EGA, Immunotherapy With Chemoradiation, and Lymph Node Metastasis in GC, December 2022
November 29, 2022
MDedge Hematology and Oncology
November 29, 2022
Commentary: New treatments and management in breast cancer, December 2022
November 29, 2022
MDedge Hematology and Oncology